Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma, highlighting the potential of personalized vaccines to reshape cancer treatment. The post From Promise to Proof: Personalized Melanoma mRNA Vaccine Delivers Phase III Success appeared first on American Association for Cancer Research (AACR) .
https://www.aacr.org/blog/2026/10/26/from-promise-to-proof-personalized-melanoma-mrna-vaccine-delivers-phase-iii-success/